… use of bluebird bio’s gene therapy Skysona in certain patients. The … any therapeutic benefit from the gene therapy. As such, patients are advised … ago. The sickle cell disease gene therapy Lyfgenia brought in $12.4 …

… adeno-associated virus (AAV)-based gene therapy developed to target CD19-positive … -cell immunotherapy. Our TransJoin™ AAV Gene Therapy Platform enables the creation of …

… of its critical RP-A501 gene therapy trial for Danon disease. The … strong progress in advancing our gene therapy” and cited the Phase 1 …

… bone marrow transplant (BMT) and gene therapy. In this exclusive podcast, the … 4th Emirates Pediatric BMT & Gene Therapy Congress? Register now → https:…

… tolerated the surgical procedure and gene therapy administration well, with no serious … Audiogene phase 1/2 gene therapy clinical trial. News release. Firstwordpharma … -progress-trial-otof-hearing-loss-gene-therapy 4. Rodríguez-Ballesteros M, Reynoso …

… -generation antiarrhythmic drugs to targeted gene therapy and non-invasive ablation modalities … By Molecule Type . Antisense oligonucleotide . Gene therapy . Hormones . Neuropeptides . Oligonucleotides . Small Molecule …

Dr. Branagan is board-certified in Internal Medicine, Medical Oncology, and Hematology. He focuses on developing novel immune-based cancer therapies, medical education, and global health. He is also an active member of several professional organizations, …

DUBLIN--(BUSINESS WIRE)--Aug 7, 2025-- × Javascript is required for you to be able to read premium content. Please enable it in your browser settings. kAm%96 v=@32= r6== 2?5 v6?6 %96C2AJ %9:C5\!2CEJ {@8:DE:4D |2C<6E :D 6IA64E65 E@ C6249 &$S a_]hg 3 …

The cell and gene therapy sectors are growing exponentially … Have a cell and gene therapy news update you’d … virus (AAV) vector-based gene therapy delandistrogene moxeparvovec-rokl (marketed … commercial rights for the gene therapy product in markets outside …